Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)

Clinical trial NCT06427668 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06427668
Sponsor: Spinogenix
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2024-07-29
Primary completion: 2025-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.